T DM1 shrank

Related by string. * TER . Ting . TS . TD . TED . Ts : t o . g t gold . g t Ag . & T . T shirt blue jeans . g t silver / dm1 : trastuzumab emtansine T DM1 . trastuzumab DM1 T DM1 . compound trastuzumab DM1 . trastuzumab DM1 . Trastuzumab DM1 . HP Pavilion dm1 #nr / Shrank : Bonds testicles shrank . shrank spooking . Turnover shrank . nonfarm payrolls shrank . unexpectedly shrank . GDP shrank * *

Related by context. Frequent words. (Click for all words.) 53 ixabepilone 53 StemEx 52 Advexin 52 Proxinium TM 52 PARP inhibitor 51 bazedoxifene 51 proteasome inhibitor 51 vismodegib 51 recurrent glioblastoma 51 bone sarcomas 51 seliciclib 50 Everolimus 50 Mipomersen 50 Amrubicin 50 gastrointestinal stromal tumors 50 BAY #-# 50 vorinostat 49 PTK ZK 49 Imprime PGG 49 gastrointestinal stromal tumors GIST 49 xenograft 49 Excellagen 49 ganetespib 49 Taxol ® 49 Ixempra 49 radiolabeled 49 oncolytic 48 enzastaurin 48 pertuzumab 48 axitinib 48 Vandetanib 48 ANG# 48 CD# expressing 48 luteinizing hormone releasing 48 Hycamtin 48 Halaven 48 Irinotecan 48 pancreatic neuroendocrine tumors 48 phase IIa clinical 48 trastuzumab Herceptin 48 RG# [001] 48 Zolinza 48 metastatic breast 48 IMC A# 47 immunomodulator 47 panitumumab 47 multicenter Phase 47 Urocidin 47 Crofelemer 47 aflibercept 47 Treanda 47 generation antisense 47 Guanilib 47 EFAPROXYN 47 GLPG# 47 Reolysin 47 collagenase 47 ZD# [001] 47 glufosfamide 47 Zactima 47 Myrexis 47 KRAS wild 47 ABRAXANE ® 47 Diamyd ® 47 Fablyn 47 MF# [002] 47 DAVANAT 47 human parthenogenetic stem 47 ADVEXIN 47 heavily pretreated 47 HER2 positive metastatic breast 47 CYC# 47 SAR# [004] 47 phase 2a 47 Phase Ib clinical 47 PEG SN# 47 IMC #B 47 Torisel 46 NY ESO 46 refractory chronic lymphocytic 46 Clevudine 46 mTOR inhibitor 46 Factor VIIa 46 CA4P 46 MOZOBIL 46 androgen independent 46 non squamous 46 talabostat 46 nucleoside analogue 46 GV# [001] 46 anticancer agent 46 GRN#L 46 olaparib 46 Sym# 46 Taxotere ® 46 Linaclotide 46 Nexavar ® 46 MEK inhibitor 46 R sorafenib tablets 46 T DM1 46 OXi#

Back to home page